{"id":23998,"date":"2026-05-03T08:16:00","date_gmt":"2026-05-03T08:16:00","guid":{"rendered":"https:\/\/sawahsolutions.com\/lap\/bioorbit-secures-historic-seed-funding-to-build-in-space-pharmaceutical-factory\/"},"modified":"2026-05-03T08:17:16","modified_gmt":"2026-05-03T08:17:16","slug":"bioorbit-secures-historic-seed-funding-to-build-in-space-pharmaceutical-factory","status":"publish","type":"post","link":"https:\/\/sawahsolutions.com\/lap\/bioorbit-secures-historic-seed-funding-to-build-in-space-pharmaceutical-factory\/","title":{"rendered":"BioOrbit secures historic seed funding to build in-space pharmaceutical factory"},"content":{"rendered":"

<\/p>\n

\n

London-based biotech BioOrbit has raised \u00a39.8 million in seed funding to develop space-based manufacturing of biologic medicines, aiming to revolutionise drug production and accessibility within the next decade.<\/p>\n<\/div>\n

\n

A London biotech co-founded by Dr Katie King and Dr Leonor Teles has raised \u00a39.8 million in seed funding to pursue an ambitious goal: building a pharmaceuticals factory in space within the next decade. According to the BioIndustry Association, the round is the largest ever completed in in-space manufacturing, with LocalGlobe and Breega co-leading the investment and support coming from Seedcamp, Auxxo Female Catalyst Fund, Type One Ventures, 7percent Ventures and others.<\/p>\n

BioOrbit is developing hardware and processes designed to use microgravity to grow more uniform protein crystals, a technique the company says could unlock drug formulations that are difficult or impossible to make on Earth. The company argues that this could help move complex biologic medicines away from hospital-based intravenous delivery and towards higher-concentration, self-injectable treatments that patients can administer at home.<\/p>\n

The scientific case for crystallisation in space has been explored for years, but commercial scale has remained elusive. UK Space notes that the absence of gravity-driven convection and sedimentation in orbit can produce larger, more orderly crystals, and points to NASA research on pembrolizumab as evidence that low-Earth orbit can improve crystal quality. BioOrbit says its aim is to turn that promise into a scalable manufacturing platform, rather than a one-off experiment.<\/p>\n

Dr King has described the funding as a step towards industrial production in orbit, saying the company is focused on scale rather than proof of concept. Industry coverage suggests the first deployments would centre on autonomous BOX manufacturing units aboard commercial space stations, with the business targeting use cases in cancer therapies and other biologic medicines where viscosity and delivery constraints limit patient access.<\/p>\n

Source Reference Map<\/h3>\n

Inspired by headline at:<\/strong> [1]<\/a><\/sup><\/p>\n

Sources by paragraph:<\/strong><\/p>\n

Source: Noah Wire Services<\/a><\/p>\n<\/p><\/div>\n

\n

Noah Fact Check Pro<\/h3>\n

The draft above was created using the information available at the time the story first
\n emerged. We\u2019ve since applied our fact-checking process to the final narrative, based on the criteria listed
\n below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
\n warrant further investigation.<\/p>\n

Freshness check<\/h3>\n

Score:
\n <\/span>10<\/p>\n

Notes:
\n <\/span>The article was published on May 3, 2026, and reports on a \u00a39.8 million seed funding round for BioOrbit, announced on April 30, 2026. The information is current and not recycled from older sources.<\/p>\n

Quotes check<\/h3>\n

Score:
\n <\/span>9<\/p>\n

Notes:
\n <\/span>The article includes a direct quote from Dr. Katie King, CEO of BioOrbit, stating: ‘This is a huge step-change in drug delivery and economics.’ A search for this quote reveals it was first used in a press release dated April 30, 2026. ([bioindustry.org](https:\/\/www.bioindustry.org\/resource\/bioorbit-secures-world-s-largest-seed-round-for-in-space-manufacturing.html?utm_source=openai)) While the quote is recent, its origin in a press release suggests it may be promotional material. The absence of independent verification of this quote raises concerns about its authenticity.<\/p>\n

Source reliability<\/h3>\n

Score:
\n <\/span>6<\/p>\n

Notes:
\n <\/span>The article is published on FemWealth, a Substack platform. Substack is a platform that allows individuals to publish content directly to subscribers, which can lead to a lack of editorial oversight and potential biases. The article cites a press release from the BioIndustry Association (BIA) as its primary source. While the BIA is a reputable organisation, the reliance on their press release without additional independent sources reduces the overall reliability of the information.<\/p>\n

Plausibility check<\/h3>\n

Score:
\n <\/span>8<\/p>\n

Notes:
\n <\/span>The claim that BioOrbit has raised \u00a39.8 million in seed funding to build a pharmaceuticals factory in space within the next decade is plausible. The concept of in-space manufacturing for pharmaceuticals is gaining traction, and the funding amount aligns with industry standards for such ventures. However, the lack of independent verification and reliance on a single source raises questions about the accuracy of the claim.<\/p>\n

Overall assessment<\/h3>\n

Verdict<\/span> (FAIL, OPEN, PASS): FAIL<\/span><\/p>\n

Confidence<\/span> (LOW, MEDIUM, HIGH): MEDIUM<\/span><\/p>\n

Summary:
\n <\/span>The article presents information about BioOrbit’s recent funding round and plans for in-space pharmaceutical manufacturing. However, it relies primarily on a press release from the BioIndustry Association, which is directly associated with BioOrbit, and includes a quote from Dr. Katie King that originates from the same press release. The lack of independent verification and reliance on a single source raise significant concerns about the accuracy and objectivity of the information. Given these issues, the content does not meet the standards for publication under our editorial indemnity.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

London-based biotech BioOrbit has raised \u00a39.8 million in seed funding to develop space-based manufacturing of biologic medicines, aiming to revolutionise drug production and accessibility within the next decade. A London biotech co-founded by Dr Katie King and Dr Leonor Teles has raised \u00a39.8 million in seed funding to pursue an ambitious goal: building a pharmaceuticals<\/p>\n","protected":false},"author":1,"featured_media":23999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[],"class_list":{"0":"post-23998","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-london-news"},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/posts\/23998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/comments?post=23998"}],"version-history":[{"count":1,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/posts\/23998\/revisions"}],"predecessor-version":[{"id":24000,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/posts\/23998\/revisions\/24000"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/media\/23999"}],"wp:attachment":[{"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/media?parent=23998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/categories?post=23998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sawahsolutions.com\/lap\/wp-json\/wp\/v2\/tags?post=23998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}